Aesthetic Medical International Holdings Group Limited
DB:3FMA Stock Report
Market Cap: €11.4m
Aesthetic Medical International Holdings Group Valuation
Is 3FMA undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6
Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 3FMA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 3FMA (€0.21) is trading below our estimate of fair value (€1.6)
Significantly Below Fair Value: 3FMA is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 3FMA?
Key metric: As 3FMA is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for 3FMA. This is calculated by dividing 3FMA's market cap by their current
revenue.
What is 3FMA's PS Ratio?
PS Ratio
0.1x
Sales
CN¥726.67m
Market Cap
CN¥86.48m
3FMA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Sales vs Industry: 3FMA is good value based on its Price-To-Sales Ratio (0.1x) compared to the European Healthcare industry average (0.7x).
Price to Sales Ratio vs Fair Ratio
What is 3FMA's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
3FMA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
0.1x
Fair PS Ratio
n/a
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 3FMA's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.